Cancer is the leading cause of death worldwide. Of the various therapeutic approaches, chemotherapy is the most widely used treatment. Among the various side effects associated with this treatment, taste alterations (TAs) have received little attention, even though they have a serious impact on the nutritional aspect and quality of life (QoL) of patients. TAs concern 75% of the patients receiving chemotherapy, and this figure is still considered to be underestimatedbeacuse could be due both to inadequate attention and to the absence of specific subjective tools able to fully evaluate TAs in patients undergoing chemotherapy.
The CiTAS scale for evaluating taste alteration induced by chemotherapy: State of the art on its clinical use / Simeone, S.; Esposito, M. R.; Gargiulo, G.; Lanzuise, A.; Botti, S.; Serra, N.; Continisio, G. I.; Rea, T.; Guillari, A.. - In: ACTA BIO-MEDICA DE L'ATENEO PARMENSE. - ISSN 0392-4203. - 90:6-S(2019), pp. 17-25. [10.23750/abm.v90i6-S.8278]
The CiTAS scale for evaluating taste alteration induced by chemotherapy: State of the art on its clinical use
Gargiulo G.;Continisio G. I.;Rea T.;Guillari A.
2019
Abstract
Cancer is the leading cause of death worldwide. Of the various therapeutic approaches, chemotherapy is the most widely used treatment. Among the various side effects associated with this treatment, taste alterations (TAs) have received little attention, even though they have a serious impact on the nutritional aspect and quality of life (QoL) of patients. TAs concern 75% of the patients receiving chemotherapy, and this figure is still considered to be underestimatedbeacuse could be due both to inadequate attention and to the absence of specific subjective tools able to fully evaluate TAs in patients undergoing chemotherapy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
